This national patient safety alert has been issued by the NHS England National Patient Safety team. It instructs all organisations providing emergency departments and cancer services to take steps to reduce the risk of harm from delayed administration of rasburicase for tumour lysis syndrome (TLS). All actions should be completed by 9 March 2026. National […]
Read More on the NHS website.